Targeting STARD4/EGFR axis inhibits growth and overcomes lenvatinib resistance in hepatocellular carcinoma.
靶向 STARD4/EGFR 轴可抑制肝细胞癌的生长并克服乐伐替尼耐药性
期刊:Genes and Diseases
影响因子:9.4
doi:10.1016/j.gendis.2025.101556
Liu Mengting, Liu Yixin, Zheng Jiahui, An Xiangping, Wen Jiayong, Zhu Fengchi, Jia Jin, Guo Dan, Chen Nana
